Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey


Barman H. A. , Ozcan S., Atici A., Ozgokce C., Ozturk A., Kafali A. E. , ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.23, sa.2, ss.79-85, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objective: Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid metabolism which arises due to deficient or absent activity of lysosomal alpha-galactosidase A (alpha-Gal A). This may be associated with increased left ventricular (LV) wall thickness and may mimic the morphological features of hypertrophic cardiomyopathy. The purpose of this study was to define the ratio of occurrence of FD to the manifestation of unexplained left ventricular hypertrophy (LVH).